Back
Revance Therapeutics Stock Price Chart
This DeFi Coin Could 10x Soon... I Advise You Get In Now!
Discover this DeFi diamond before the next surge
Sell
34
RVNC
Revance Therapeutics
Last Price:
3.78
Seasonality Move:
2.55%
7 Day Trial
ALL ACCESS PASS
$
7
Earn Your Weekly "Paycheck" with Chuck's Secret Income Strategy!
Act now for your path to extra income!- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RVNC is experiencing slight selling pressure.
Revance Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.58 | Buy |
| 20-day SMA: | 3.94 | Sell |
| 50-day SMA: | 4.89 | Sell |
| 200-day SMA: | 9.71 | Sell |
| 8-day EMA: | 3.67 | Buy |
| 20-day EMA: | 3.95 | Sell |
| 50-day EMA: | 4.7 | Sell |
| 200-day EMA: | 9.99 | Sell |
Revance Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.37 | Sell |
| Relative Strength Index (14 RSI): | 41.27 | Sell |
| Chaikin Money Flow: | -576646 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.61 - 4.57) | Sell |
| Bollinger Bands (100): | (4.33 - 7.33) | Sell |
Revance Therapeutics Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Revance Therapeutics Stock
Is Revance Therapeutics Stock a Buy?
- Revance Therapeutics share price is 3.79 while RVNC 8-day simple moving average is 3.58, which is a Buy signal.
- The stock price of RVNC is 3.79 while Revance Therapeutics 20-day SMA is 3.94, which makes it a Sell.
- Revance Therapeutics 50-day simple moving average is 4.89 while RVNC share price is 3.79, making it a Sell technically.
- RVNC stock price is 3.79 and Revance Therapeutics 200-day simple moving average is 9.71, creating a Sell signal.
RVNC Technical Analysis vs Fundamental Analysis
Sell
34
Revance Therapeutics (RVNC)
is a Sell
Is Revance Therapeutics a Buy or a Sell?
-
Revance Therapeutics stock is rated a Sell
The current Revance Therapeutics [RVNC] share price is $3.79. The Score for RVNC is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Revance Therapeutics Stock Info
Market Cap:
394.97M
Price in USD:
3.79
Share Volume:
1.84M
Revance Therapeutics 52-Week Range
52-Week High:
37.98
52-Week Low:
3.21
Sell
34
Revance Therapeutics (RVNC)
is a Sell
Revance Therapeutics Share Price Forecast
-
What is the Revance Therapeutics stock price today?
The Revance Therapeutics stock price is 3.79 USD today. -
Will RVNC stock go up or go down?
Revance Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Revance Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Revance Therapeutics is overvalued.
Is Revance Therapeutics Stock a Buy?
- Revance Therapeutics share price is 3.79 while RVNC 8-day exponential moving average is 3.67, which is a Buy signal.
- The stock price of RVNC is 3.79 while Revance Therapeutics 20-day EMA is 3.95, which makes it a Sell.
- Revance Therapeutics 50-day exponential moving average is 4.70 while RVNC share price is 3.79, making it a Sell technically.
- RVNC stock price is 3.79 and Revance Therapeutics 200-day simple moving average is 9.99, creating a Sell signal.
Fundamental Analysis of Revance Therapeutics
Is Revance Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.01 per share, an increase this year of $1.80 per share, and an increase next year of $1.21 per share.
Technical Analysis of Revance Therapeutics
Should I short Revance Therapeutics stock?
- RVNC Moving Average Covergence Divergence (MACD) indicator is -0.37, suggesting Revance Therapeutics is a Sell
- Revance Therapeutics Relative Strength Index (RSI) is 41.27, which suggest Revance Therapeutics is oversold
- The Bollinger Bands (25) for Revance Therapeutics is (3.61 - 4.57), which suggest Revance Therapeutics is a Sell
- The Bollinger Bands (100) for Revance Therapeutics is (4.33 - 7.33), which suggest Revance Therapeutics is a Sell
* Revance Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.